REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $9,588,216 | +94804.6% | 94,039 | -15.4% | 0.00% | -25.0% |
Q1 2023 | $10,103 | +148.3% | 111,121 | +3.7% | 0.00% | +100.0% |
Q4 2022 | $4,069 | -99.9% | 107,115 | -3.0% | 0.00% | +100.0% |
Q3 2022 | $2,775,000 | -19.7% | 110,433 | -2.8% | 0.00% | 0.0% |
Q2 2022 | $3,454,000 | -13.4% | 113,646 | +7.7% | 0.00% | 0.0% |
Q1 2022 | $3,987,000 | +55.2% | 105,532 | +8.3% | 0.00% | 0.0% |
Q4 2021 | $2,569,000 | -75.6% | 97,415 | -7.1% | 0.00% | -66.7% |
Q3 2021 | $10,548,000 | -55.2% | 104,836 | -37.0% | 0.00% | -57.1% |
Q2 2021 | $23,561,000 | +83.9% | 166,467 | +29.5% | 0.01% | +75.0% |
Q1 2021 | $12,813,000 | -18.1% | 128,506 | +1.6% | 0.00% | -20.0% |
Q4 2020 | $15,639,000 | +58.6% | 126,505 | +25.0% | 0.01% | +25.0% |
Q3 2020 | $9,861,000 | -43.0% | 101,220 | -8.8% | 0.00% | -42.9% |
Q2 2020 | $17,315,000 | -36.5% | 110,980 | -41.2% | 0.01% | -46.2% |
Q1 2020 | $27,262,000 | -18.6% | 188,875 | +15.2% | 0.01% | 0.0% |
Q4 2019 | $33,511,000 | +139.6% | 163,926 | -5.9% | 0.01% | +116.7% |
Q3 2019 | $13,984,000 | +9.5% | 174,165 | +28.7% | 0.01% | +20.0% |
Q2 2019 | $12,767,000 | +2998.8% | 135,312 | +2708.5% | 0.01% | +150.0% |
Q1 2019 | $412,000 | – | 4,818 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |